1.
|
6 p, 291.5 KB |
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
/
Martín, A.J.M. (Hospital General Universitario Gregorio Marañón) ;
Ortega, I. (Gendiag) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
Pachón, V. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Castellón, V. (Complejo Hospitalario de Torrecárdenas) ;
Martínez-Marín, V. (Hospital Universitario La Paz (Madrid)) ;
Salgado, M. (Complejo Hospitalario Universitario de Ourense) ;
Martínez, E. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Calzas, J. (Hospital Universitario de Fuenlabrada ( Madrid)) ;
Rupérez, A. (Hospital Universitario Fundación Jiménez Díaz) ;
Souto, Juan Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Martín, M. (Hospital General Universitario Gregorio Marañón) ;
Salas, E. (Gendiag) ;
Soria Fernández, José Manuel (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Venous thromboembolism (VTE) is a leading cause of death among patients with cancer. Outpatients with cancer should be periodically assessed for VTE risk, for which the Khorana score is commonly recommended. [...]
2018 - 10.1038/s41416-018-0027-8
British Journal of Cancer, Vol. 118 Núm. 8 (january 2018) , p. 1056-1061
|
|
2.
|
11 p, 1.6 MB |
Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
/
Ruiz-Artacho, Pedro (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Lecumberri, Ramón (Instituto de Salud Carlos III) ;
Trujillo-Santos, Javier (Hospital General Universitario Santa Lucía (Cartagena, Múrcia)) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
López Núñez, Juan José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Peris, María Luisa (Consorci Hospitalari Provincial de Castelló) ;
Díaz-Pedroche, Carmen (Hospital Universitario 12 de Octubre (Madrid)) ;
Lobo, José Luis (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
López Jiménez, Luciano (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
López Reyes, Raquel (Hospital Universitari i Politècnic La Fe (València)) ;
Jara-Palomares, Luis (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Pedrajas, José María (Hospital Clínico San Carlos (Madrid)) ;
Mahé, Isabelle (Hôpital Louis Mourier) ;
Monreal, Manuel (Universidad Católica San Antonio de Murcia) ;
Universitat Autònoma de Barcelona
Cancer is a widely heterogeneous disease, and the natural history of patients with cancer-associated thrombosis may differ according to the cancer site. Lung cancer is the most common malignancy, and a leading cause of death. [...]
2022 - 10.3390/cancers14174127
Cancers, Vol. 14 (august 2022)
|
|
3.
|
10 p, 441.5 KB |
Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs : Results from the RIETE Registry
/
Debourdeau, Philippe (Centre Hospitalier Joseph Imbert) ;
Bertoletti, Laurent (Université Jean Monnet Saint-Étienne) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
López Núñez, Juan José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gómez-Cuervo, Covadonga (Hospital Universitario 12 de Octubre (Madrid)) ;
Mahé, Isabelle (Hôpital Louis Mourier) ;
Otero-Candelera, Remedios (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Adarraga, Maria Dolores (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
López-Miguel, Patricia (Complejo Hospitalario Universitario de Albacete) ;
Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
The natural history of isolated lower-limb superficial vein thrombosis (SVT) in cancer patients is not well understood. To address this gap, we analyzed data from the RIETE registry, which included 110 cancer patients with isolated SVT, 1695 cancer patients with isolated deep vein thrombosis (DVT), and 1030 non-cancer patients with SVT. [...]
2023 - 10.3390/cancers15072034
Cancers, Vol. 15 (march 2023)
|
|
4.
|
5 p, 218.4 KB |
Francisco Domínguez Matito, Juan Manuel Escudero Baztán, Rebeca Lázaro Niso, eds., "Mujer y sociedad en la literatura del Siglo de Oro"
/
Font Paz, Carme 1972- (Universitat Autònoma de Barcelona)
Obra ressenyada: Francisco DOMÍNGUEZ MATITO, Juan Manuel ESCUDERO BAZTÁN, Rebeca LÁZARO NISO (eds. ), Mujer y sociedad en la literatura del Siglo de Oro. Madrid: Iberoamericana-Vervuert, 2020.
2023 - 10.5565/rev/anuariolopedevega.500
Anuario Lope de Vega, Vol. 29 (2023) , p. 549-553 (Reseñas)
|
|
5.
|
5 p, 97.0 KB |
Risk of recurrent venous thromboembolism in patients with autoimmune diseases : data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
/
Borjas Howard, Jaime (University Medical Centre Groningen, University of Groningen) ;
Ruiz-Sada, Pablo (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
de Leeuw, Karina (University Medical Centre Groningen) ;
López-Jiménez, Luciano (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
Marchena, Pablo Javier (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Madridano, Olga (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
Debourdeau, Philippe (Institut Sainte Catherine (Avignon, França)) ;
Meijer, Karina (University Medical Centre Groningen) ;
Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). [...]
2021 - 10.1111/bjh.17549
British Journal of Haematology, Vol. 194 (june 2021) , p. 195-199
|
|
6.
|
|
7.
|
8 p, 205.5 KB |
Edoxaban for the Long-Term Therapy of Venous Thromboembolism : Should the Criteria for Dose Reduction be Revised?
/
Camporese, Giuseppe (University Hospital of Padova (Pàdua, Itàlia)) ;
Simioni, Paolo (University Hospital of Padova (Pàdua, Itàlia)) ;
Di Micco, Pierpaolo (Ospedale Buon Consiglio Fatebenefratelli) ;
Fernández-Capitán, Carmen (Hospital Universitario La Paz (Madrid)) ;
Rivas, Agustina (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
Sahuquillo, Joan Carles (Hospital Municipal de Badalona) ;
Villares, Paula (Hospital Universitario HM Sanchinarro (Madrid)) ;
Prandoni, Paolo (University of Padua) ;
Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Edoxaban is used for venous thromboembolism (VTE) treatment. Real-life data are lacking about its use in long-term therapy. We aimed to assess the efficacy and the safety of edoxaban for long-term VTE treatment in a real-life setting. [...]
2020 - 10.1111/cts.12876
Clinical and Translational Science, Vol. 14 (october 2020) , p. 335-342
|
|
8.
|
12 p, 775.3 KB |
Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer
/
Quintanar, Teresa (Hospital General Universitario de Elche) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
Gallardo, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Barba, Raquel (Hospital Universitario Rey Juan Carlos (Madrid)) ;
Obispo, Berta (Hospital Universitario Infanta Leonor) ;
Díaz-Pedroche, Carmen (Hospital Universitario 12 de Octubre (Madrid)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Up to 20% of cancer patients will develop some manifestation of venous thromboembolic disease (VTD) during their clinical course. VTD greatly impacts morbidity, mortality, quality of life and pharmaceutical expenditure. [...]
2020 - 10.1007/s12094-020-02477-6
Clinical & Translational Oncology, Vol. 23 (september 2020) , p. 697-708
|
|
9.
|
18 p, 3.1 MB |
'Che son la Pia' : Liminal Female Figures of Intercession in Blake's illustrations of the Commedia
/
Font Paz, Carme, 1972- (Universitat Autònoma de Barcelona. Departament de Filologia Anglesa i de Germanística)
While female icons are neither scant nor marginal in Dante's Divine Comedy, with Francesca and Beatrice at the centre of the story, other women in the Commedia justify their presence as figures that enact and enable transitions, but not necessarily change: Pia in Purgatorio, Canto V, and her plea to Dante to be remembered among the living; Lucia carrying Dante in his sleep up to the threshold of purgatory (Canto IX); or Matilda waiting for Dante on the banks of the river Lethe in Purgatorio (Canto XXIX). [...] Si bé les icones femenines no són escasses ni marginals en la Divina Comèdia de Dante, sent Francesca i Beatrice el centre de la història, altres dones de la Comèdia justifiquen la seva presència com a figures que promulguen i permeten transicions, però no necessàriament canvien: Pia en el Purgatori, Cant V, i la seva súplica a Dante perquè sigui recordada entre els vius; Lucia portant a Dante adormit fins al llindar del purgatori (Cant IX); o Matilda esperant a Dante a la vora del riu Leteu en el Purgatori (Cant XXIX). [...] Si bien los iconos femeninos no son escasos ni marginales en la Divina Comedia de Dante, siendo Francesca y Beatrice el centro de la historia, otras mujeres de la Comedia justifican su presencia como figuras que promulgan y permiten transiciones, pero no necesariamente cambian: Pía en el Purgatorio, Canto V, y su súplica a Dante para que sea recordado entre los vivos; Lucía llevando a Dante adormecido hasta el umbral del purgatorio (Canto IX); o Matilde esperando a Dante a orillas del río Leteo en el Purgatorio (Canto XXIX). [...]
2020 - 10.5565/rev/dea.140
Dante e l'Arte, Vol. 7 (2020) , p. 155-172 (Monogràfic)
|
|
10.
|
14 p, 251.1 KB |
Cancer-Associated Thrombosis : Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus
/
Pachón, Vanessa (Hospital Universitario Ramón y Cajal (Madrid)) ;
Trujillo-Santos, Javier (Hospital General Universitario Santa Lucía (Cartagena, Múrcia)) ;
Domènech, Pere (Hospital Universitari de Bellvitge) ;
Gallardo, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
González-Porras, José Ramón (Instituto de Investigación Biomédica de Salamanca) ;
Pérez-Segura, Pedro (Hospital Clínico San Carlos (Madrid)) ;
Maestre, Ana (Hospital General Universitario de Elche) ;
Mateo, José (Institut d'Investigació Biomèdica Sant Pau) ;
Muñoz Martin, Andrés (Hospital General Universitario Gregorio Marañón) ;
Peris, María Luisa (Consorci Hospitalari Provincial de Castelló) ;
Lecumberri, Ramón (Clínica Universidad de Navarra) ;
Universitat Autònoma de Barcelona
Despite the growing interest and improved knowledge about venous thromboembolism in cancer patients in the last years, there are still many unsolved issues. Due to the limitations of the available literature, evidence-based clinical practice guidelines are not able to give solid recommendations for challenging scenarios often present in the setting of cancer-associated thrombosis (CAT). [...]
2018 - 10.1055/s-0038-1675577
TH Open: Companion Journal to Thrombosis and Haemostasis, Vol. 2 (november 2018) , p. e373-e386
|
|